Although the expression of the PR is routinely assessed in BC, the clinical value of PR expression is not so strongly established as it is for ER expression; rather, the presence of an intact and functionally active ER pathway is implied when the PR is expressed [16]. This evidence concerns the gene ESR1 and breast cancer.